Global Alliance for TB Drug Development donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details.

Table of contents

Basic donee information

ItemValue
Country South Africa
Facebook page TBAllianceCE
Websitehttps://www.tballiance.org/
Donate pagehttps://www.tballiance.org/donate
Twitter usernametballiance
Wikipedia pagehttps://en.wikipedia.org/wiki/TB_Alliance

Donation amounts by donor and year for donee Global Alliance for TB Drug Development

Donor Total 2015 2014 2010 2006
Bill and Melinda Gates Foundation (filter this donee) 442,839,461.00 146,885,605.00 26,640,000.00 164,910,032.00 104,403,824.00
Total 442,839,461.00 146,885,605.00 26,640,000.00 164,910,032.00 104,403,824.00

Full list of donations in reverse chronological order (6 donations)

DonorAmount (current USD)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation145,000,000.002015-11-10Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop and introduce novel drugs and drug regimens to make treatment of all forms of TB more effective, safe and affordable; Aid type: Project-type interventions. Affected regions: Bilateral, unspecified.
Bill and Melinda Gates Foundation1,885,605.002015-10-23Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to accelerate global health drug development and registration by creating a public database of chemistry, manufacturing, and controls (CMC) regulatory requirements for target global health countries; Aid type: Project-type interventions. Affected regions: Bilateral, unspecified.
Bill and Melinda Gates Foundation25,000,000.002014-11-03Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to support the Shortening Treatments by Advancing Novel Drugs (STAND) trial, which is the first Phase III registration trial testing a drug regimen for use against both Tuberculosis and multidrug-resistant Tuberculosis (MDR-TB); Aid type: Project-type interventions. Affected regions: Bilateral, unspecified.
Bill and Melinda Gates Foundation1,640,000.002014-05-06Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need; Aid type: Project-type interventions. Affected regions: Bilateral, unspecified.
Bill and Melinda Gates Foundation164,910,032.002010-11-19Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate development of anti-tuberculosis treatments by filling the drug development pipeline with novel candidates, developing single drug candidates, and working as a part of the Critical Path to TB drug Regimens; Aid type: Project-type interventions. Affected regions: Bilateral, unspecified.
Bill and Melinda Gates Foundation104,403,824.002006-05-09Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to decrease tuberculosis mortality by developing new anti-TB treatments; Aid type: Project-type interventions. Affected regions: Bilateral, unspecified.